Sign In
to Vote &
Create Storyboards.
 
(Canadian Medical Association Journal) A new Canadian guideline for managing opioid use disorders lays out the optimal strategies for the treatment of opioid addiction, including recommending opioid agonist treatment with buprenorphine-naloxone as the preferred first-line treatment. The guideline, published in CMAJ, was created for a wide range of health care providers to address an urgent need for evidence-based treatment of opioid use causing overdoses and death.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard